Bill H Chang Selected Research

Bill H Chang Research Topics

Disease

12	Neoplasms (Cancer) 11/2023 - 05/2009
11	Leukemia 01/2024 - 01/2013
11	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2021 - 09/2012
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 06/2015
4	Lymphoma (Lymphomas) 01/2024 - 08/2016
4	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2017 - 05/2013
2	Philadelphia Chromosome 01/2021 - 01/2018
1	T-Cell Leukemia (Leukemia, T Cell) 10/2023
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020
1	Juvenile Myelomonocytic Leukemia 01/2018
1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 01/2018
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 09/2017
1	Hodgkin Disease (Hodgkin's Disease) 09/2017
1	Hyperbilirubinemia 08/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2016
1	Hematologic Neoplasms (Hematological Malignancy) 01/2016
1	Bacteremia 07/2015
1	Fever (Fevers) 07/2015
1	Infections 07/2015
1	Neutropenia 07/2015
1	Residual Neoplasm 06/2015
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 09/2006
1	Neuroblastoma 09/2006
1	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 09/2006

Drug/Important Bio-Agent (IBA)

5	venetoclaxIBA 11/2023 - 01/2016
5	Phosphotransferases (Kinase)IBA 01/2020 - 01/2013
4	Dasatinib (BMS 354825)FDA Link 01/2018 - 09/2012
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2016 - 05/2013
2	Azacitidine (5 Azacytidine)FDA Link 01/2024 - 11/2023
2	Decitabine FDA Link 01/2022 - 01/2020
2	Vorinostat FDA Link 01/2022 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2013
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2016 - 08/2016
2	Pre-B Cell ReceptorsIBA 03/2015 - 11/2012
1	NivolumabIBA 01/2024
1	AntibodiesIBA 10/2023
1	Mitogen-Activated Protein Kinase 14IBA 01/2022
1	doramapimodIBA 01/2022
1	p38 Mitogen-Activated Protein KinasesIBA 01/2022
1	Aurora Kinase AIBA 11/2021
1	blinatumomabIBA 01/2021
1	ibrutinibIBA 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2018
1	Protein Tyrosine PhosphatasesIBA 01/2018
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2018
1	Imatinib Mesylate (Gleevec)FDA Link 01/2018
1	Monoclonal AntibodiesIBA 09/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	tirbanibulinIBA 01/2017
1	Bromodeoxyuridine (BrdU)IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Serine (L-Serine)FDA Link 12/2016
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 12/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2016
1	Threonine (L-Threonine)FDA Link 12/2016
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 12/2016
1	Tyrosine (L-Tyrosine)FDA Link 12/2016
1	Oncogene Proteins (Oncogene Protein)IBA 12/2016
1	quizartinibIBA 08/2016
1	Lipase (Acid Lipase)FDA Link 08/2016
1	ponatinibIBA 01/2016
1	Bcl-2-Like Protein 11IBA 01/2016
1	CoagulaseIBA 07/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2015
1	MicroRNAs (MicroRNA)IBA 06/2015
1	preemptIBA 06/2015
1	Anaplastic Lymphoma KinaseIBA 06/2015
1	SurvivinIBA 04/2015
1	sepantroniumIBA 04/2015
1	InterleukinsIBA 05/2013
1	Tumor Biomarkers (Tumor Markers)IBA 10/2012
1	AutoantigensIBA 09/2006
1	Rituximab (Mabthera)FDA Link 09/2006

Therapy/Procedure

11	Therapeutics 11/2023 - 09/2006
4	Drug Therapy (Chemotherapy) 01/2022 - 08/2016
1	Cranial Irradiation 01/2018
1	Investigational Therapies (Experimental Therapy) 09/2017
1	Molecular Targeted Therapy 05/2013